ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
2.490
+0.050 (2.05%)
At close: Aug 1, 2025, 4:00 PM
2.410
-0.080 (-3.21%)
After-hours: Aug 1, 2025, 7:59 PM EDT
CTI BioPharma Employees
As of December 31, 2024, ReShape Lifesciences had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees decreased by 13 or -41.94% compared to the previous year.
Employees
18
Change (1Y)
-13
Growth (1Y)
-41.94%
Revenue / Employee
$398,611
Profits / Employee
-$192,389
Market Cap
5.94M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18 | -13 | -41.94% |
Dec 31, 2023 | 31 | -9 | -22.50% |
Dec 31, 2022 | 40 | -7 | -14.89% |
Dec 31, 2021 | 47 | 10 | 27.03% |
Dec 31, 2020 | 37 | -1 | -2.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RSLS News
- 8 days ago - ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewsWire
- 11 days ago - ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewsWire
- 11 days ago - ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewsWire
- 4 weeks ago - ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System - GlobeNewsWire
- 5 weeks ago - ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - GlobeNewsWire
- 5 weeks ago - ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys - GlobeNewsWire
- 5 weeks ago - ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology - GlobeNewsWire
- 7 weeks ago - ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets - GlobeNewsWire